HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunodetection of squamous cell carcinoma-associated variant of nuclear protein.

Abstract
A new monoclonal antibody, MAb C63.3, was developed by immunizing mice with the high molecular weight fraction of the cytoplasmic proteins from the cervical squamous cell carcinoma. In Western blotting, MAb C63.3 reacted with cytoplasmic and chromatin antigens expressed by cervical and vulvar squamous cell carcinomas and much weaker with normal cervical tissue and skin cells. Different molecular variants of C63.3 chromatin antigens were found in normal tissues (heavy variants, M(r) 65,000 and 59,000) compared to squamous cell carcinomas (light variant, M(r) 48,000). Diagnostic value of the cancer-associated M(r) 48,000 antigen is discussed. MAb C63.3 was internalized by cells and bound to the chromatin which suggests that antigen(s) C63.3 might represent a receptor for a yet unknown ligand (growth factor). It is suggested that the high molecular weight C63.3 antigens play a role in maintaining the nonmalignant phenotype.
AuthorsE M Rakowicz-Szulczynska, D G McIntosh, M Perry, M L Smith
JournalGynecologic oncology (Gynecol Oncol) Vol. 60 Issue 2 Pg. 255-63 (Feb 1996) ISSN: 0090-8258 [Print] United States
PMID8631548 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Chromatin
Topics
  • Animals
  • Antibodies, Monoclonal
  • Antigens, Neoplasm (analysis)
  • Biomarkers, Tumor (analysis)
  • Blotting, Western
  • Carcinoma, Squamous Cell (chemistry)
  • Chromatin (chemistry)
  • Cytoplasm (chemistry)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Genital Neoplasms, Female (chemistry)
  • Humans
  • Intracellular Membranes (chemistry)
  • Mice
  • Mice, Inbred BALB C
  • Molecular Weight
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: